SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2021 Biotech Stock Picking Charity Contest
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: technetium who wrote (139)4/26/2021 2:22:42 PM
From: Arthur Radley   of 307
 
Vaccine maker Emergent's CEO sold $10 million in stock before company ruined Johnson & Johnson doses - The Washington Post

This is why the inspection of production facilities must be done---how many times can this CEO get away with the deception and basically scamming investors with his inside trading(dumping). Once is enough, but this company has multiple cases where they put patient's lives in danger. Ricin, and this company was providing doses of faulty manufactured medicine. Regular investors have seen their stock drop by 50% while the CEO was dumping! Great!!!

With the pandemic basically closing the FDA operations, then you factor in that nearly 85% of our drugs use drug ingredients that are manufactured in China and India---who in their right mind would want the assignment to fly into India and inspected their facilities?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News